Halozyme Therapeutics, Inc.HALONASDAQ
Loading
EPS Over TimeContracting
Percentile Rank86
3Y CAGR+20.8%
5Y CAGR+22.4%
Studio
Year-over-Year Change

Earnings per share

3Y CAGR
+20.8%/yr
Annual compound
5Y CAGR
+22.4%/yr
Consistent
Percentile
P86
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM2.61-25.4%
20243.50+64.3%
20232.13+43.9%
20221.48-48.3%
20212.86+201.1%
20200.95+290.0%
2019-0.50+10.7%
2018-0.56-221.7%
20170.46+156.8%
2016-0.81-